Addressing adolescent substance use with a public health prevention framework: the case for harm reduction
Adolescence is a developmental stage defined in part by risk-taking. Risk-taking is critical to
normal development and has important benefits including trying new activities and exploring …
normal development and has important benefits including trying new activities and exploring …
Stimulant misuse among youth
NJ LaBossier, SE Hadland - Current problems in pediatric and adolescent …, 2022 - Elsevier
Rates of stimulant use, including misuse of prescription stimulants and use of cocaine and
methamphetamine, are rising rapidly among adolescents and young adults (“youth”) …
methamphetamine, are rising rapidly among adolescents and young adults (“youth”) …
[HTML][HTML] Young adult substance use and healthcare use associated with screening, brief intervention and referral to treatment in pediatric primary care
S Sterling, S Parthasarathy, A Jones, C Weisner… - Journal of Adolescent …, 2022 - Elsevier
Purpose Screening, brief intervention, and referral to treatment (SBIRT) may impact future
comorbidity and healthcare utilization among adolescents screening positive for substance …
comorbidity and healthcare utilization among adolescents screening positive for substance …
Leveraging the full continuum of care to prevent opioid use disorder
JD Cance, ET Adams, EJ D'Amico, A Palimaru… - Prevention …, 2023 - Springer
Substance use disorder prevention programs are most effective when matched
appropriately to the baseline risk of the population. Individuals who misuse opioids often …
appropriately to the baseline risk of the population. Individuals who misuse opioids often …
[HTML][HTML] Dopamine supersensitivity: A novel hypothesis of opioid-induced neurobiological mechanisms underlying opioid-stimulant co-use and opioid relapse
Emergent harms presented by the co-use of opioids and methamphetamine highlight the
broader public health challenge of preventing and treating opioid and stimulant co-use …
broader public health challenge of preventing and treating opioid and stimulant co-use …
Investigating the co-occurrence of marijuana use and prescription opioid misuse with multiple suicide attempts among adolescents with a history of suicidal ideation
This study investigated the co-occurrent association of marijuana use and prescription
opioid misuse with multiple suicide attempts among adolescents with a history of suicidal …
opioid misuse with multiple suicide attempts among adolescents with a history of suicidal …
Using the Centers for Disease Control and Prevention's National Syndromic Surveillance Program data to monitor trends in US emergency department visits for …
ML Zwald, KM Holland, DA Bowen, TR Simon… - Annals of emergency …, 2022 - Elsevier
Study objective We describe trends in emergency department (ED) visits for initial firearm
injury encounters in the United States. Methods Using data from the Centers for Disease …
injury encounters in the United States. Methods Using data from the Centers for Disease …
Pediatric suicides reported to US poison centers
JA Ross, MH Woodfin, SV Rege, CP Holstege - Clinical Toxicology, 2022 - Taylor & Francis
Introduction As the pediatric mental health crisis worsens, the rate of adolescent suicide-
related cases is increasing, including adolescent cases of self-poisoning. Methods Data …
related cases is increasing, including adolescent cases of self-poisoning. Methods Data …
Prevalence and correlates of methamphetamine use in transitional age youth experiencing homelessness or housing instability in San Francisco, CA
Introduction Substance use, including methamphetamine use, is a contributing factor in HIV
acquisition and treatment. Stimulant use is linked to mental health yet there is limited data …
acquisition and treatment. Stimulant use is linked to mental health yet there is limited data …
Analysis of rising cases of adolescent opioid use presentations to the emergency department and their management
A Sidlak, B Dibble, M Dhaliwal, P Bottone… - Drug and alcohol …, 2024 - Elsevier
Objective We sought to answer the question of how adolescents (ages 12–17 years old) with
opioid-related presentations are currently managed in the ED. The two main outcomes were …
opioid-related presentations are currently managed in the ED. The two main outcomes were …